At this time of year, when we are all busy and ready to be with family, sharing food and maybe presents, we sincerely ask you to consider “buying” a philanthropic gift on Giving Tuesday: use the list below and donate to PACPI in honor of a loved one.
Giving Tuesday is December 2. We have a day for giving thanks. We have two days for getting deals. Now, we have #GivingTuesday, a day dedicated to giving back. World AIDS Day is December 1 so we see this as a perfect opportunity to give to programs helping people directly affected by HIV/AIDS, like PACPI’s moms and babies.
READ MORE >>
FOR IMMEDIATE RELEASE
Pediatric AIDS Chicago Prevention Initiative receives March of Dimes Community Award
Chicago, IL (November 19, 2014) – Pediatric AIDS Chicago Prevention Initiative (PACPI) received a 2014 Community Award from the March of Dimes Illinois Chapter to implement preconception and interconception health education for HIV-positive women.
PACPI will use March of Dimes funding to create a training curriculum for PACPI’s HIV-specific prenatal classes that will be culturally appropriate and applicable to group settings. The key messages will focus on health between pregnancies and how to plan and prepare for a pregnancy when one or both partners are HIV-positive.
“We are excited to work with March of Dimes to bring more resources to help women plan for a healthy future,” said Anne Statton, PACPI Executive Director. “This partnership will bring these messages to a population often facing poverty, homelessness, violence, and other challenges that direct their attention away from their reproductive health.”
READ MORE >>
The National Institutes of Health (NIH) announced this week that the findings from their PROMISE randomized clinical trial shows that taking a three-drug regimen during pregnancy prevents mother-to-child HIV transmission more effectively than taking one drug during pregnancy, another during labor and two more after giving birth.
“This is another important step in our efforts to define the best approaches toward the goal of eliminating of mother-to-child HIV transmission globally,” Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH.
The study enrolled more than 3,500 HIV-infected pregnant or post-partum women who did not meet national criteria for receiving anti-HIV treatment and more than 3,200 HIV-exposed infants of these women in India, Malawi, South Africa, Tanzania, Uganda, Zambia and Zimbabwe.
The participating women and children are being followed until two years after the last child is born to address questions about the safety and efficacy of anti-HIV drug regimens taken during the breastfeeding period. The study also is assessing maternal health after the breastfeeding period among women in good immune health who either stop or continue taking triple-drug anti-HIV regimens.